// App-Quantinova.ai

P1-02-03 : Circulating inflammatory markers, growth factors, and tumor associated antigens in women with early stage breast cancer receiving neoadjuvant metformin

Researchers

Presenter

  • RJ Dowling

Principal Investigators

  • S Niraula

  • MC Chang

  • M Ennis

  • V Stambolic

  • PJ Goodwin

Medical Centers

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Applied Statistician, Markham, ON, Canada

  • Department of Pathology and Laboratory Medicine, Toronto, ON, Canada

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

  • The Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada

  • Cancer Care Manitoba & University of Manitoba, Winnipeg, Manitoba, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • C reactive protein

  • Cancer antigen 15-3

  • Epidermal growth factor

  • Interleukin 6

  • Interleukin-8

  • Sex hormone binding globulin

  • Vascular endothelial growth factor A

Drug/Treatment

  • Metformin Hydrochloride

  • CA15-3

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved